Although schizophrenia onset usually occurs in late adolescence or early adulthood, much research shows that its seeds are planted early in life and that eventual onset occurs at the end of a neurodevelopmental process leading to aberrant brain functioning. This idea, along with the fact that current therapies are far from fully effective, suggests that preventive treatments may be needed to achieve an ideal outcome for schizophrenia patients and those predisposed to the disorder. In this article, we review the methodological challenges that must be overcome before effective preventive interventions can be created. Prevention studies will need to define the target population. This requires the identification of risk factors that will be useful in selecting at-risk people for preventive treatment. We review currently identified risk factors for schizophrenia: genes, psychosocial factors, pregnancy and delivery complications, and viruses. We also review 3 different types of prevention programs: universal, indicated, and selective. For schizophrenia, we distinguish prevention programs that target prodromal cases and those that target the disorder's premorbid precursors. Although those targeting prodromal cases provide a useful framework for early treatment of the disorder, studies of premorbid individuals are needed to design a truly preventive treatment. See page 535 for research funding and support and page 537 for author affiliations.
incidence, as well as the predictability of risk factors and the efficacy of interventions across different subgroups. Without such attention, a prevention trial will likely have minimal power to detect preventive impact. We will show how 3 epidemiologic terms indicating the predictability of a risk factor, the frequency of that risk factor in the population, and the effectiveness of a preventive intervention targeting that risk factor all work together to determine the effect of an intervention strategy on preventing a target outcome.
Understanding Risk and Protective Factors
Defining the Target Population Modern prevention science is based on the concept of targeting or altering the known risk factors or enhancing the known protective factors that necessarily precede a disorder's onset (9, 10) . A risk factor is an element that, when present, is associated with a higher probability of subsequent disorder than that experienced by the population without such a factor. A protective factor is one that lowers risk. For example, estrogen is believed to be a protective factor for schizophrenia, since female sex predicts a delayed onset and reduced prevalence of the disorder (11) . By discovering gene variants that predispose to disorders, molecular genetic studies may lead to more precisely defined target populations. For example, the epsilon 4 variant of the apolipoprotein E gene has been shown to increase the risk for late-onset Alzheimer's disease, the epsilon 2 variant protects against the disease, and other variants have no effect (12) .
Although risk and protective factors must precede the outcome of interest, they may be either distant or proximal to onset. Genes and pregnancy and delivery complications are distal risk factors for schizophrenia (13) , while drug use is a proximal risk factor for psychosis. Risk and protective factors can be further classified as modifiable or nonmodifiable. Carrying a susceptibility gene for schizophrenia is an example of a nonmodifiable risk factor (there is no gene therapy for schizophrenia). Pregnancy and delivery complications provide a good example of modifiable risk factors because these could be modified by good pre-, peri-, and postnatal care.
We can further classify risk and protective factors with regard to whether they impact individuals or groups. Risk factors occurring at the individual level, such as pregnancy and delivery complications, affect a single individual at a time, not an entire community. Other examples of individual risk factors include child abuse, head injury, and the neurotoxic effects of drug abuse. Risk factors that occur at the group level affect many individuals at once. For example, the school shooting in Columbine, Colorado, traumatized the entire school. Lack of resources in low-income areas leads to poor education, which can impact an entire school district.
Twin studies have provided a unique view of the nature of environmental risk factors for psychiatric disorders. The twinstudy method allows researchers to estimate the relative importance of 3 main sets of risk factors on psychopathology: genes, shared environment, and unshared environment. Shared environment refers to any environmental feature shared by siblings. Examples include social class and the nature of discipline from parents. Unshared environment refers to any environmental feature that siblings do not share. Examples include head injuries and exposure to different peer groups. Twin studies suggest that most environmental risk factors for psychopathology are those not shared by siblings (14, 15) .
For any disease, understanding the parameters of the target population helps create a strategy for preventive intervention. We take as examples the prevention of 2 diseases-pellagra and syphilis-that in the past were responsible for a large portion of mental disorders, including psychoses, worldwide. By understanding the effective prevention strategies for these known causes of mental disorders, we can compare alternative prevention strategies aimed at those processes where the etiology is not fully known. The first prevention strategy, illustrated by the prevention of pellagra-associated psychosis, involves the direct targeting of modifiable risk factors. In the southern US, pellagra was responsible for a large percentage of hospitalizations for mental disorders in the early part of the 20th century. After it was recognized that a dietary deficiency in riboflavin caused pellagra, direct targeting of this risk factor by dietary supplementation virtually eliminated this disease and its consequent psychosis in many parts of the world. This dietary strategy reaches a large segment of the population, and we can therefore refer to it as population-based.
Identifying risk factors can also lead to the development of interventions that target a specific group of individuals who share that risk factor. Untreated syphilis can lead to neurosyphilis with symptoms of grandiosity and psychotic behaviour, as well as dementia and depression. Although the disease has not been eliminated, antibiotic treatment has virtually eliminated the most serious mental conditions associated with its later stages. Two common targeted screening strategies involve screening couples before marriage and screening commercial sex workers. Appropriate treatment is then provided to those with positive serological tests. The geographic distribution of syphilis cases is also not random. Impoverished communities living with limited clinic access and in close proximity to trucking thoroughfares are at elevated risk for contracting the disease (16) .
In these examples, prevention programs first screen target individuals based on a risk characteristic (for example, sex worker), but the intervention is directed at another factor that is known to be causal in the development of the disorder (syphilis infection). Another approach is to select a group based on a modifiable risk factor and then eliminate that risk factor. For example, improving the care of pregnant women with schizophrenia or pregnant women known to have partners with schizophrenia could reduce pregnancy and delivery complications and, consequently, the risk of schizophrenia in their children. As another example, some data suggest that the nature of family relationships may be a risk factor for symptoms of schizophrenia (for example, [17] ). Thus, family interventions might reduce stressors that affect vulnerable family members. This could reduce the risk for schizophrenia among vulnerable adolescents.
Our Current Knowledge of Risk and Protective Factors for Schizophrenia
In this section, we briefly review our current knowledge of risk and protective factors for schizophrenia, focusing on a group of factors for which there is evidence of a causal link with the disorder. Factors associated with "schizotaxia," the predisposition to schizophrenia, may predict subsequent schizophrenia, but these have been reviewed elsewhere (18) .
Genes
The cumulative evidence from over a century of research overwhelmingly implicates genes in the etiology of schizophrenia (19) (20) (21) . Twin studies consistently find higher concordance rates of schizophrenia among monozygotic (MZ) twins than among dizygotic (DZ) twins (22) , and adoption studies show that familial transmission is mostly mediated by genetic, not adoptive, relationships (23, 24) . No single major "schizophrenia gene" has yet been discovered (25) , and it is likely that no such gene exists. Mathematical analyses suggest that many genes are involved in the etiology of schizophrenia (26) , and that the effect of any single gene on risk for the disorder is likely to be small (27) .
Traditionally, genetic risk for schizophrenia has been estimated from the pattern of schizophrenia prevalence in relatives. A review of 40 European studies, selected for similarities in diagnostic and ascertainment procedures and performed between 1920 and 1987 (19) , showed the following approximate lifetime risks for schizophrenia to relatives of schizophrenia patients: parents, 6.0%; siblings, 9.0%; offspring having 1 parent with schizophrenia, 13.0%; and offspring having 2 parents with schizophrenia, 46.0%. Note that the risk to offspring exceeds the risk to parents, which is unexpected because similar risks to first-degree biological relatives (who share on average 50% of genes) would be anticipated in a standard genetic model. The difference occurs because schizophrenia has an adverse effect on the probability of reproducing, whereas parents, by definition, have already reproduced. Thus, parents are on average a more selective and less vulnerable group than are offspring. The risks to seconddegree relatives (who share on average 25% of genes) ranged from 6.0% for half-siblings to 2.0% for uncles and aunts. First cousins, a type of third-degree relative (who share on average 12.5% of genes) had an average risk of 2.0%. Using more stringent diagnostic criteria, modern family studies find a lower overall prevalence in families but have confirmed that the pattern of risk is consistent with the idea that genes underlie the familial transmission of the disorder (28, 29) .
The discovery of specific susceptibility genes for schizophrenia may yield more accurate and useful estimates of the risk to individuals than can be inferred from the degree of relatedness to affected family members. The isolation of such genes may also assist in identifying individuals, families, and even whole groups of families who may be at either an elevated or reduced risk for schizophrenia. Through large-scale collaborative research endeavours and metaanalysis, several gene variants have been found to confer excess risk for the disorder. For example, Williams and others identified an association between a mutation in the 5-HT 2A receptor gene and schizophrenia in a large, multicentre case-control study (30) and verified this association by metaanalysis (31) . A functional polymorphism of the D 3 subtype of dopamine receptor has also been found to be associated with schizophrenia (32, 33) , but this association appears to be strongest for, if not exclusive to, samples of European descent. Another dopamine receptor subtype gene, that for the D 2 subtype, contains a functional gene variant also associated with schizophrenia (34) . This variant is rare in the population (prevalence 5.0%), but when present, it significantly increases risk for schizophrenia.
Interestingly, genes implicated in schizophrenia code for proteins that are integral to monoamine neurotransmission, and this fits in with our current understanding of the major neurotransmitter dysfunctions of schizophrenia. More research is needed to identify other genes associated with schizophrenia, to determine how they affect the brain, and to determine whether the genes identified combine in an additive or interactive fashion to modify the risk for schizophrenia. The findings to date demonstrate the complexity and heterogeneity of the genetic etiology of schizophrenia.
Psychosocial Factors
Kinney and others found elevations on the Thought Disorder Index (TDI) in biological relatives of schizophrenia patients, compared with normal control subjects (35) . In contrast, elevations on the TDI were not evident in the adoptive relatives of either schizophrenia patients or control subjects. Consistent findings have been reported by others (36) (37) (38) (39) . Wahlberg and others showed that young adult offspring of mothers with schizophrenia were more likely to be thought-disordered when raised by adoptive mothers who showed " communication deviance," whereas adoptees raised by adoptive parents with low communication deviance were less likely to show thought disorder (38) . In contrast, control subject adoptees born from mothers without schizophrenia showed no relation between adoptee thought disorder and communication deviance in the adoptive parents. Thus, communication deviance appears to be a risk factor only for people with a genetic vulnerability to schizophrenia.
Pregnancy and Delivery Complications
Many studies have found an elevated prevalence of pregnancy and delivery complications surrounding the births of individuals who eventually developed schizophrenia. For example, schizophrenia patients are more likely to have been born prematurely and to have had relatively low birth weights (40, 41) . Other studies have confirmed a relation between various pregnancy and delivery complications and subsequent schizophrenia (42, 43) , but McNeil (44) suggested, and others confirmed (45) (46) (47) (48) , that complications leading to oxygen deprivation or trauma might be the most relevant to the subsequent development of schizophrenia.
Zornberg and others studied 693 adults born between 1959 and 1966 and followed up for an average of 19 years (48) . Their experience of fetal and neonatal complications had been recorded at the time of their birth. Hypoxic ischemia-related complications predicted a doubling of the risk for psychosis, especially for psychoses not associated with mood disorders. Nonpsychotic mood disorders were unrelated to hypoxic ischemia-related complications. The data show a strikingly elevated risk for schizophrenia and other nonaffective psychoses associated with this classification of antecedent hypoxic ischemia-related fetal or neonatal complications.
Several studies have found that pregnancy and delivery complications tend to be more common in sporadic schizophrenia patients (that is, those having no affected close relatives) than in familial schizophrenia patients (49) (50) (51) (52) . McNeil and others found that pregnancy and delivery complications among MZ twin pairs were more common among those discordant for schizophrenia than among those concordant for schizophrenia (53) . A similar trend has been reported by Onstad and others (54) . Further, among MZ twins discordant for schizophrenia, pregnancy and delivery complications were more likely to involve the twin with schizophrenia than the cotwin without schizophrenia (55) . However, a review of 6 systematically ascertained twin samples found no differences in birth weight between schizophrenic and well MZ cotwins (56) .
It is also possible that pregnancy and delivery complications merely activate the genetic predisposition to schizophrenia. For example, DeLisi and others found more pregnancy and delivery complications among siblings with schizophrenia than among siblings without schizophrenia in families having at least 2 siblings with the disorder (57) . This suggests that pregnancy and delivery complications work in combination with familial factors. Similarly, among children of mothers with schizophrenia, pregnancy and delivery complications predict subsequent psychiatric abnormality (58) . Among these high-risk children, the children who developed schizophrenia had been exposed to more pregnancy and delivery complications (59) This work also identified a group of highrisk children who had the least complicated births. Because these children had milder schizophrenia-like conditions but not psychosis, the investigators suggested that schizophrenia might result from the interaction of susceptibility genes with environmental events such as pregnancy and delivery complications. In this model of etiology, neither risk factor alone is sufficient for the development of the disorder.
Viruses
The idea that schizophrenia is caused by a virus is consistent with epidemiologic and clinical observations (60) . Schizophrenia patients are more likely to have been born during the late winter and spring months, when the fetus is at increased risk for exposure to viruses (61) (62) (63) . Several indices of heightened immune-system responsiveness are apparent in schizophrenia patients, including elevations in herpes antibody titre, immunoglobulins, cytomegalovirus antibody titre, interleukin-2 receptors, alpha interferon, and autoantibodies (64) (65) (66) (67) (68) (69) (70) . Of note, an allelic association between schizophrenia and the human leukocyte antigen (HLA) A9 locus has been reported (71) . Since the HLA loci are known to be associated with autoimmune diseases, these data led Wright and others to suggest that some cases of schizophrenia may have an autoimmune basis (72).
Mednick and others studied a Finnish cohort who were exposed to the influenza epidemic of 1957 at various stages of their fetal life (73) . Those exposed to the epidemic during their second trimester of development were at increased risk for subsequent schizophrenia. However, a Scottish study failed to find an increased risk for schizophrenia associated with influenza epidemics in 1918, 1919, and 1957. Analyses limited to the city of Edinburgh in 1957 supported the viral hypothesis, but the nationwide data did not (74) . Further, only limited evidence of an association between viral epidemics and schizophrenia was found in an American study (75) .
Barr and others criticized the negative studies on methodological grounds and replicated the Finnish results in a Danish sample (76) . Takei and others found that female subjects but not male subjects exposed to influenza epidemics 5 months prior to birth had an increased rate of schizophrenia in adulthood (77). Sham and others found a link between schizophrenia and maternal influenza but suggested that it would account for less than 2% of schizophrenia cases (78) . In contrast, Crow and Done did not find evidence to support the hypothesis that maternal influenza was a risk factor for schizophrenia (79) .
Several studies report that nonfamilial schizophrenia patients are more likely to have been born during the winter months (and hence, are more likely to have been exposed to viruses), compared with familial schizophrenia patients (80) (81) (82) (83) . For example, Roy and others reported that 32% of sporadic schizophrenia patients were born between December 21 and March 21, compared with 18% of familial patients (82) . Goldstein and others delineated a cluster of schizophrenia patients characterized by poor premorbid history, flat affect, winter birth, and no family history of schizophrenia (80) . This cluster was enriched with male sporadic schizophrenia cases.
Other studies have implicated winter or spring births as a risk factor for familial schizophrenia. For example, Pulver and others found higher rates of schizophrenia among relatives of probands born between February and May. The lowest rates among relatives occurred for probands born between October and January. This effect was observed for all relatives of female probands but only for younger relatives of male probands. The older relatives of male probands were actually less likely to have schizophrenia if the proband had been born between February and May (84).
Buka and others studied the association between maternal cytokines in pregnancy and the subsequent development of psychotic disorders in offspring (85) . Their sample included mothers of 27 adults with psychotic disorders and 50 matched control subjects. Using enzyme immunoassay, they analyzed serum samples for interleukin-1 beta (IL-1beta), interleukin-2 (IL-2), interleukin-6 (IL-6), interleukin-8 (IL-8), and tumour necrosis factor alpha (TNF-alpha). Maternal levels of TNFalpha were significantly elevated among the adults with psychotic disorders. Higher maternal cytokine levels predicted an increased likelihood of psychosis. They did not find significant differences between case and control mothers in the serum levels of IL-1beta, IL-2, IL-6, and IL-8.
In another study of the same sample, Buka and others reported that maternal levels of IgG-and IgM-class immunoglobulins taken prior to the delivery of the child were significantly elevated among the offspring with psychosis (86) . They also found a significant association between maternal antibodies to herpes simplex virus type 2 glycoprotein gG2 and subsequent psychosis in offspring. They did not find significant differences between case and control mothers either in the serum levels of IgA-class immunoglobulins, or in specific IgG antibodies to herpes simplex virus type 1, cytomegalovirus, toxoplasma gondii, rubella virus, human parvovirus B19, Chlamydia trachomatis, or human papillomavirus type 16.
A Typology of Prevention Approaches Based on Target Population
The terms "universal," "selective," and "indicated" provide a valuable way to distinguish preventive interventions. All 3 preventive intervention strategies refer to the different target populations to which they are applied. Universal preventive interventions are applied to whole populations. A childhood vaccination program, a fluoride treatment of the water supply, programs to improve dietary and exercise habits, and statemandated health education courses are all examples of universal preventive interventions.
Universal Prevention Programs
There are now several successful universal intervention programs-for example, classroom, peer, school, and family interventions for children as young as first grade-aimed at preventing conduct disorder (CD) (5-7). These programs are designed to deliver interventions to all children, even though some components may be delivered in the classroom, some on the playground, and some at parent-family meetings. Components focus on such areas as classroom management of behaviour by the teacher, parental monitoring and supervision, and positive peer relations, all known to protect against later development of CD. One universal intervention strategy of potential benefit in regard to schizophrenia would focus on lowering the incidence of pregnancy and delivery complications through improved pre-, peri-, and postnatal care.
Selective Prevention Programs
Conversely, selective interventions target specific subgroups. Selective interventions target those who are at elevated risk, based on group-level characteristics that are not directly related to etiology. For example, children raised in families where there is a recent divorce are at higher risk for internalizing and externalizing problems (87) . An intervention that provides parenting skills to divorcing parents during this critical time is selective, because it targets an entire subpopulation at risk, even though there are certainly cases where some children fare much better after the divorce (88) . Other examples of selective interventions include a program to prevent depression when an adult becomes unemployed (89), a family program aimed at reducing depression in children whose parents have a depressive disorder (2), and a drug-abuse prevention program for children of heroin users (90) .
An important challenge for schizophrenia prevention programs is how to identify subpopulations for selective interventions (91) . A simple method would be to choose adolescent children or siblings of schizophrenia patients. This group has a tenfold elevated risk for the disorder and is entering the age period of greatest risk for the onset of psychosis. However, even though the elevation in risk for this group is substantial, only 10% can be expected to develop schizophrenia or a related psychotic disorder. This magnitude of risk is not sufficient to define the at-risk population for selective prevention trials (unless there existed a low-risk treatment that was inexpensive to administer).
Fortunately, research suggests that measures of schizotaxia may some day improve risk prediction to the level where it would be useful in defining populations at very high risk for schizophrenia (18) . For example, in 2 independent studies of children of schizophrenia patients, Fish described a syndrome of motor abnormalities that predicted subsequent schizophrenia or related disorders (92) . Similarly, in both the Copenhagen and New York high-risk projects, neuromotor impairment predicted schizophrenia onset (93, 94) . These findings are consistent with Walker and Lewine's finding of poorer fine and gross motor coordination in videotapes of children who subsequently developed schizophrenia (95) . In addition to neuromotor impairment, attentional deficits have also been found to predict subsequent schizophrenia and related disorders (for example, [94] ).
Given the established link between neuropsychological and social impairment in child relatives, it is not surprising that psychosocial dysfunction also predicts subsequent schizophrenia and related disorders. In the Israeli high-risk study, subjects who eventually developed schizophrenia-related disorders had been either shy and withdrawn or aggressive and antisocial as children (96) . Walker and Lewine's videotape study described the children who developed schizophrenia as having had poorer eye contact, more negative affect, and diminished social responsiveness (95) . Similarly, in the Copenhagen high-risk study, teacher-rated social behaviours predicted subsequent schizophrenia (93) .
Thus, schizotaxic traits among children of schizophrenia patients may predict subsequent psychosis. Yet, more needs to be known about the diagnostic accuracy of schizotaxic traits (that is, their sensitivity and specificity as predictors of psychosis [97] ) before they can be used in prevention trials. Many of the studies reviewed above are difficult to interpret because the outcome they predict (that is, schizophrenia and related disorders) is rather broad. Because trials with antipsychotics would not be warranted for preventing some related disorders (for example, schizotypal personality disorder [SPD]), future work needs to estimate precisely the degree to which schizotaxia can predict schizophrenia. Moreover, because no diagnostic criteria are available for schizotaxia, it is not possible to compare the diagnostic accuracy of schizotaxia and SPD as predictors of psychosis. Future work will need to address this issue.
Theoretically, risk prediction should improve dramatically after molecular genetic studies discover genes for schizophrenia. Notably, linkage studies have discovered regions of the genome that may harbour schizophrenia genes. Five promising chromosomal regions are 22q11-q13, 6p23, 8p22-21, 15q13-q14, and 10p14-p12 (98) (99) (100) (101) (102) (103) (104) (105) (106) (107) . However, although these findings are promising, no schizophrenia gene has yet been found. Once geneticists have identified the mutations leading to schizophrenia, this information can be combined with schizotaxic signs to delineate a group at very high risk for the disorder.
Indicated Prevention Programs
Indicated preventive interventions target individuals who either have signs but are currently asymptomatic for a disorder or are in an early stage of a progressive disorder. It should be noted that in its original usage pertaining to heart disease, the term "indicated intervention" referred only to those who were asymptomatic; that is, those with borderline hypertension. Because there are no universal signs of schizophrenia, indicated interventions for this disorder have a somewhat broader definition than those used in other health fields where clear signs are available (for example, borderline hypertension for heart disease) (108).
The importance of indicated preventive interventions for schizophrenia was suggested by Wyatt's idea that early intervention for schizophrenia might alter the course of the illness (109). His review of 21 studies found that patients treated with antipsychotic medicine during their first or second hospitalization had a better outcome than patients treated later in the course of illness. Others have suggested that early treatment, especially with newer agents, may preserve brain plasticity and reduce the clinical deterioration occurring with chronic schizophrenia (110, 111) . It is also possible that, rather than having a neuroprotective effect, early treatment mitigates the social consequences of schizophrenic psychopathology, which may result in better outcome by allowing the easier reintegration of patients into their social networks. This line of reasoning has motivated the creation of early detection and indicated preventive intervention projects seeking to treat schizophrenia patients during their prodrome or first episode (93, 110, (112) (113) (114) (115) (116) (117) . Using signs such as social withdrawal, subtle changes in thinking or affect, and mild psychosis, these projects identify people in the very early stages of schizophrenia.
For low base-rate disorders such as schizophrenia, one might conclude that broad, population-based programs, and especially universal programs, would not be as effective as targeted ones based on very high-risk subgroups. After all, targeting a large group of subjects, most of whom have very low risk for schizophrenia, seems inefficient, compared with focusing more intensively on a smaller number of subjects with higher risk. This inefficiency could occur when risk factors identified in a high-risk group do not generalize to the population For example, because children of parents with schizophrenia have a high genetic loading for the disorder, it is possible that environmental risk factors play a weaker role than they do in the general population. Second, there are many situations wherein an intervention delivered to everyone has greater effect than one given to a smaller group, even though the smaller group has higher risk. Vaccinations, for example, count on reducing the infectivity rate by reducing the pool without inoculation. Similarly, behaviour-based interventions can be highly effective when peers, classmates, or neighborhood families participate together, rather than individually (7).
There is an important difference between indicated interventions for schizophrenia and the selective interventions described in the prior section. Whereas the indicated interventions target people who have already begun to express signs and symptoms of the illness, the selective interventions target people who only express the premorbid condition known as schizotaxia. This difference is crucial: it is possible that different interventions will be needed during the premorbid and prodromal stages of illness. For example, reducing a child's exposure to stressful experiences may be effective in childhood, during the premorbid stage. In late adolescence, by contrast, reducing stress among families of prodromal patients may modify the course of illness, but it cannot change the cumulative impact of stress that occurred in earlier years.
Other Characteristics of Prevention Programs That Affect Intervention Effectiveness
We have described how the dimensional aspect of broadly population-based and targeted risk groups helps identify the target group for a prevention program. Other criteria are also important, such as the timing and duration of the intervention, the person or persons who will deliver the intervention, and the social context within which it is delivered. A complete mapping of the combined risk and protective factors over the life course at the individual or contextual levels would provide valuable knowledge for designing prevention programs. Even incomplete mapping or mappings generated by combining findings across different samples can be useful. This is the perspective of developmental epidemiology (118) , which guides our understanding of the development, formation, and interactions of a defined population of individuals within their environments.
A developmental perspective on schizophrenia suggests that we should consider not the predictability of risk factors across age groups but their predictability when measured within and across different stages of development. It seems likely that schizophrenia genes will express themselves differently at these different stages. For example, current neurobiological theories of schizophrenia implicate dysfunction of the frontal cortex and of circuits connecting to that region. Because frontal cortex is developing throughout childhood, it would be reasonable to suspect age-related changes in the expression of premorbid predictors of schizophrenia.
Within a developmental epidemiology framework, numerous factors demand consideration when models of disease causation are being developed and ultimately tested in preventive intervention trials. For example, the timing of the intervention and its position relative to other interventions will dramatically influence the prevention program's success. To illustrate: a schizophrenia prevention program can aim for improved host resistance (that is, prophylactic neuroleptics), behavioural change (that is, improved attention and processing), and environmental change (that is, less stressful peer and intrafamily relationships), each of which must be implemented at the appropriate stage in both the individual's development and in the target's progression.
Determining the proper timing of an intervention is sometimes difficult, because it is known that, for schizophrenia, risk factors exist much earlier than the period within which incidence rises. It is critical to intervene during the premorbid period, in the stage prior to disease onset, or even prior to prodromal onset, when frank signs and symptoms are not evident: targeting early risk and protective factors can lead to longterm benefits. For example, the Israeli High-Risk Study of offspring of parents with schizophrenia reported a dramatic difference in risk, based on social adaptational status. Only those who performed poorly in each important stage of life from preschool, early school, and adolescence were at risk for schizophrenia; none of those who made successful transitions through most of these stages were diagnosed with the disorder (119) . Thus, poor social adaptation throughout the life course among offspring of parents with schizophrenia constitutes a particularly high-risk developmental process.
It should be noted that low neighborhood socioeconomic status, as well as family poverty status, both have a direct impact on a child's aggressive behaviour ratings from elementary school to early adolescence (120) . Poverty is also a risk factor for schizophrenia (121) . Aggressiveness, particularly when accompanied by shy or withdrawn behaviour, is strongly associated with poor peer and parent relationships and low academic performance. When concentrated in a genetically vulnerable group of children, this cluster of multiple problems may also be an important developmental pathway toward later psychopathology. Further, in 2 independent studies of children of schizophrenia patients, Fish and others described a syndrome of motor abnormalities that predicted subsequent schizophrenia or related disorders (92) . Similarly, in both the Copenhagen and New York high-risk projects, neuromotor impairment predicted schizophrenia onset (93) . These findings are consistent with Walker and Lewine's finding of poorer fine and gross motor coordination in videotapes of children who subsequently developed schizophrenia (95) .
In addition to neuromotor impairment, attentional deficits have also been found to predict subsequent schizophrenia and related disorders (122) .
Variation in Intervention Impact
To test these developmental epidemiologic or early prevention approaches, we will need to compare the growth trajectories of these risk behaviours across time. Change in these proximal risk targets should theoretically carry forward to changes on the more distal outcome. Thus, to examine impact on proximal growth trajectories and distal diagnostic outcomes, statistical growth-modelling techniques used to chart changes in proximal risk behaviours can be combined with the analysis of a distal binary outcome-whether diagnosis or another outcome. Similarly, the techniques can also be combined with a survival analysis involving time to diagnosis. Both theoretical and empirical work indicate that an intervention effect is likely to differ by early risk status, so recent evaluations examine the intervention's effect on different subgroups of the population that are often divided based on their early risk status (123) . In schizophrenia research, one would logically attempt to examine (based on sample size limitations) whether an intervention varies in effectiveness among those who have a family risk (including a history of schizophrenia); or pregnancy and delivery complications, or early attention problems.
A consistent finding across several broad, population-based, preventive interventions is that their impact can be highest among the highest-risk group, even though the target group varies considerably in risk (124) . Because high-risk groups tend also to have few protective factors, there may be more opportunity for improved outcomes should the intervention focus on building the right protective factors (125) . It is not necessarily true, however, that a more targeted intervention, focused on just the highest-risk group, would be equally successful. Risk status on measures such as attention processing can vary across time (126); a one-time targeted intervention would miss those who developed the risk shortly afterwards (127) . This is not the case for a universal intervention, since everyone would be exposed to it.
In preventive interventions, implementation can refer to behavioural, systemic, or prescription practices. Of course, preventive intervention effectiveness can diminish considerably when the intervention is not delivered at full strength. Currently there is no uniformly accepted pharmacologic approach for high-risk adolescent populations at risk for schizophrenia, such as the population being studied in a natural setting by Cornblatt and others (128) . About one-half of such adolescents are now being given antidepressants, with higher levels being given to those with more severe symptoms. While there is no definitive evidence of benefit or harm from such medication, the overall benefit or potential harm is attenuated by this lack of implementation standard for the field. For broad-based preventive interventions where intervention involves delivering multiple components, there is ample evidence that preventive effectiveness varies with implementation level (6) , and for a multiyear intervention, preventive effectiveness varies by exposure level, determined by entrances and exits to a school system (1).
The findings on participation in preventive interventions are somewhat less generalizable. Participation can vary from nearly 100% for interventions within classroom settings (7) to less than 50% when individuals are asked to attend group sessions (89). Usually, the participation level is not related in a strong systematic way to risk. Sometimes, higher participation levels occur in low-risk groups, and sometimes they occur in higher-risk groups. Nevertheless, since there can be no intervention impact for those subjects who choose not to participate, the overall participation level strongly affects the preventive effectiveness for the population. That is, if one-half of the eligible subjects participate in a preventive intervention, we can anticipate roughly one-half the effect of a preventive intervention delivered to the entire population.
Summary
This paper presents several methodological concepts guiding the development of prevention programs and suggests ways to apply these methods to the prevention of schizophrenia. To date, several important risk factors for schizophrenia have been identified. These present options for developing prevention programs. A few prevention programs that focus exclusively on high-risk groups (especially those showing prodromal symptoms of schizophrenia) are now being tested in randomized trials.
To date, there have not been any attempts to evaluate either the broader population prevention strategies or the strategies that apply population-screening methods to select high-risk groups. For example, reducing pregnancy and delivery complications may have some impact on reducing the prevalence of schizophrenia and of other disorders for which such complications are risk factors. Alternatively, it may be feasible to screen births for pregnancy and delivery complications relevant to the subsequent development of schizophrenia. Within that high-risk sample, one could screen for other risk factors, such as family history of schizophrenia, early signs of inattention, poor motor skills, or poor socialization.
We should work now to diminish gaps in our knowledge about the development of schizophrenia in the population. Future work needs to answer several key questions: 1) What are the best early predictors of subsequent schizophrenia? 2) Can these indicators predict illness with sufficient accuracy to justify preventive intervention programs? 3) What are the relative strengths of risk factors that predict schizophrenia? 4) Are these large enough to justify prevention efforts? 5) What types of treatments would prevent schizophrenia in high-risk individuals? 6) Under what conditions, and in combination with which other risk and protective factors, are the effects of a risk factor greatest, and when are they lowest?
As we have shown, the methodological and statistical technologies needed to answer these questions are available. If these are combined with the contemporary tools of neuroscience and treatment research, answers to these questions and the eventual prevention of schizophrenia should be achievable.
